- Clear All
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove theAVMA governance & leadershipfilter AVMA governance & leadership
- Remove theProduction medicinefilter Production medicine
- Remove thePractice managementfilter Practice management
- Remove theAnimal diseasesfilter Animal diseases
- Remove theInsurancefilter Insurance
JAVMA news
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during the Executive Board…
JAVMA news
Regulating equine plasma products
The Executive Board has approved a position statement on the regulation of equine plasma products.
JAVMA news
Warning added to euthanasia products
The FDA's Center for Veterinary Medicine is adding an environmental warning to labels of pentobarbital-containing euthanasia
AVMA news
FDA CVM lays out innovation plan for new animal, veterinary products
Leaders with the Food and Drug Administration’s Center for Veterinary Medicine recently outlined the agency’s plan to support the development of safe…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
Aquatic Veterinary Medicine Committee
The Aquatic Veterinary Medicine Committee advises the Board of Directors onmatter related to aquatic animal health and aquatic veterinary medicine.
JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
JAVMA news
FDA advises stricter oversight for hydrocodone products
The Food and Drug Administration believes stricter oversight is necessary for hydrocodone combination products to curb abuse
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
JAVMA news
Class I recall issued for digoxin product
Veterinarians who use the human drug Digitek (digoxin tablets, USP, all strengths) to treat their patients should be aware that a Class I
JAVMA news
Antimicrobial sales outpace meat production
Agriculture-related sales of antimicrobials rose by one-sixth in five years, and that included a one-fifth rise in sales of those considered medically…
policy
Use of technology in veterinary medicine
The AVMA supports responsible and ethical development and use of technology that can benefit and protect public health, animal health and welfare, and…
JAVMA news
AVMA recognizes excellence in veterinary medicine
During AVMA Convention 2017 this July in Indianapolis, the AVMA bestowed awards to recognize excellence in veterinary medicine.
JAVMA news
Four flea, tick products linked to seizures, ataxia
Four flea and tick products may cause seizures, tremors, and lost coordination in some cats and dogs.
JAVMA news
FDA bars import of cow reproductive hormone products
Federal regulators warned that three cattle-use reproductive hormone products sold in the U.S. are unapproved, and it is now illegal to import or…
JAVMA news
The corporatization of veterinary medicine
Corporate-owned veterinary practices have been around for roughly 30 years, starting in 1987 when VCA bought its first independently owned companion…
JAVMA news
Chronicling a century of veterinary medicine
JAVMA’s first issue came out in October 1915. In the ensuing 100 years, the Journal has had a marked impact on AVMA members, and vice
JAVMA news
A time of transition at the FDA Center for Veterinary Medicine
Dr. Stephen F. Sundlof became the director of the FDA Center for Food Safety and Applied Nutrition, effective Jan. 7, after serving for more than a…
JAVMA news
Fish medicine gaining veterinarians, who hope for specialty recognition
A growing corps of veterinarians is working in fish medicine, and two veterinary organizations are working to create a board specialty in fish…
blog
AVMA voices veterinary needs to FDA about cannabis products
The U.S. Food and Drug Administration (FDA) should provide regulatory clarity about expectations for the labeling, safety, and use of cannabis-derived…
policy
Use of prescription drugs in veterinary medicine
Veterinary prescription drugs are those drugs restricted by federal law to use by or on the order of a licensed veterinarian.
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
Animal Medicinal Drug Use Clarification Act (AMDUCA)
Information for veterinarians on use of the Animal Medicinal Drug Use Clarification Act (AMDUCA). Use with our interactive Extralabel Drug Use (ELDU)…